top
Search terms
Results 1 - 5 of 5 - ordered by :
Ejhf

Letter to the EditorAuthors Gastelurrutia Paloma, Corresponding authorICREC Research Group Health Research Institute Germans Trias i Pujol Carretera Canyets s/n, Badalona, Spain Tel: +34 649406427 ...

European Journal of Heart Failure, Gastelurrutia, Paloma, Lupón, Josep, Bayes‐Genis, Antoni

Date : 01/06/2013 Item size : 62759 bytes
Ejhf

Tel: +31 50 3612355, Fax: +31 50 3614391, Email: d.j.van.veldhuisen@umcg.nl Search for more papers by this author McMurray John J.V. BHF Glasgow Cardiovascular Research Centre, University of Glasgow, ...

European Journal of Heart Failure, Veldhuisen, Dirk J., McMurray, John J.V.

Date : 01/01/2013 Item size : 127197 bytes
Ejhf

Letter to the EditorAuthors Gastelurrutia Paloma, Corresponding authorICREC Research Group Health Research Institute Germans Trias i Pujol Carretera Canyets s/n, Badalona, Spain Tel: +34 649406427 ...

European Journal of Heart Failure, Gastelurrutia, Paloma, Lupón, Josep, Bayes‐Genis, Antoni

Date : 01/06/2013 Item size : 64334 bytes
Ejhf

Tel: +31 50 3612355, Fax: +31 50 3614391, Email: d.j.van.veldhuisen@umcg.nl Search for more papers by this author McMurray John J.V. BHF Glasgow Cardiovascular Research Centre, University of Glasgow, ...

European Journal of Heart Failure, Veldhuisen, Dirk J., McMurray, John J.V.

Date : 01/01/2013 Item size : 128659 bytes
Escardio

Prof. Zannad points out that, “Rivaroxaban is approved at higher doses to treat conditions such as atrial fibrillation (AF) and venous thromboembolism, but in COMMANDER HF, patients were ...

Date : 28/08/2018